These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1565 related articles for article (PubMed ID: 20465107)

  • 21. Temporal variation in diabetic macular edema measured by optical coherence tomography.
    Frank RN; Schulz L; Abe K; Iezzi R
    Ophthalmology; 2004 Feb; 111(2):211-7. PubMed ID: 15019364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes.
    Byeon SH; Chu YK; Lee H; Lee SY; Kwon OW
    Ophthalmology; 2009 Oct; 116(10):1949-59.e8. PubMed ID: 19699533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema.
    Bolz M; Schmidt-Erfurth U; Deak G; Mylonas G; Kriechbaum K; Scholda C;
    Ophthalmology; 2009 May; 116(5):914-20. PubMed ID: 19410950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optical coherence tomography findings in persistent diabetic macular edema: the vitreomacular interface.
    Ghazi NG; Ciralsky JB; Shah SM; Campochiaro PA; Haller JA
    Am J Ophthalmol; 2007 Nov; 144(5):747-754. PubMed ID: 17869207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema.
    Kang SW; Park CY; Ham DI
    Am J Ophthalmol; 2004 Feb; 137(2):313-22. PubMed ID: 14962423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retina rejuvenation therapy for diabetic macular edema: a pilot study.
    Pelosini L; Hamilton R; Mohamed M; Hamilton AM; Marshall J
    Retina; 2013 Mar; 33(3):548-58. PubMed ID: 23023529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
    Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
    Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of internal limiting membrane peeling in surgery for idiopathic macular hole and the correlation between function and retinal morphology.
    Christensen UC
    Acta Ophthalmol; 2009 Dec; 87 Thesis 2():1-23. PubMed ID: 19912135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystoid puncture for chronic cystoid macular oedema.
    Singh RP; Margolis R; Kaiser PK
    Br J Ophthalmol; 2007 Aug; 91(8):1062-4. PubMed ID: 17229807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography.
    Tran TH; de Smet MD; Bodaghi B; Fardeau C; Cassoux N; Lehoang P
    Br J Ophthalmol; 2008 Jul; 92(7):922-7. PubMed ID: 18577643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Measurement of macular edema in retinal vein occlusion using optical coherence tomography and its visual prognosis].
    Zhang HR; Wang X; Lu XR; Yang YF; Liu F
    Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):910-6. PubMed ID: 16271177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-spot subthreshold infrared laser to treat diabetic macular edema.
    Squirrell DM; Stewart AW; Joondeph BC; Danesh-Meyer HV; McGhee CN; Donaldson ML
    Retina; 2008 Apr; 28(4):615-21. PubMed ID: 18398365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser.
    Parodi MB; Spasse S; Iacono P; Di Stefano G; Canziani T; Ravalico G
    Ophthalmology; 2006 Dec; 113(12):2237-42. PubMed ID: 16996596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local retinal sensitivity in relation to specific retinopathy lesions in diabetic macular oedema.
    Soliman W; Hasler P; Sander B; Larsen M
    Acta Ophthalmol; 2012 May; 90(3):248-53. PubMed ID: 20809906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitrectomy for persistent diffuse diabetic macular edema.
    Stolba U; Binder S; Gruber D; Krebs I; Aggermann T; Neumaier B
    Am J Ophthalmol; 2005 Aug; 140(2):295-301. PubMed ID: 16023067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical applications of the MicroPulse diode laser.
    Moorman CM; Hamilton AM
    Eye (Lond); 1999 Apr; 13 ( Pt 2)():145-50. PubMed ID: 10450372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy.
    Lee CM; Olk RJ; Akduman L
    Ophthalmic Surg Lasers; 2000; 31(4):292-300. PubMed ID: 10928666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unilateral macular oedema secondary to retinal venous congestion without occlusion in patients with diabetes mellitus.
    Larsen M
    Acta Ophthalmol Scand; 2005 Aug; 83(4):428-35. PubMed ID: 16029265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.